Results 11 to 20 of about 1,763,579 (103)

NI4OS-Europe Sustainability Report

open access: yes, 2023
This document describes NI4OS-Europe activities and outcomes produced between 1 September 2019 and 28 February 2023, highlighting the contribution NI4OS-Europe made to the EOSC governance to achieve the vision of EOSC, to implementation of collaborative ...
Judit Fazekas-Paragh   +6 more
core   +1 more source

NI4OS-Europe Business models recommendations

open access: yes, 2022
“Business models recommendations” provides a set of recommendations related to business modelling aspects, based on the state of the art in NI4OS-Europe countries and recommendations adapted from the leading pan-EU initiatives.
Eleni Toli   +3 more
core   +1 more source

NI4OS-Europe Promotional package with updates

open access: yes, 2021
Promotional package with updates presents the full package of the project branding and dissemination material that constitutes a powerful tool of the NI4OS-Europe marketing and communication strategy. The updated and enriched set of effective promotional
Dimitra Kotsokali
core   +1 more source

NI4OS-Europe Intermediate report on liaison activities

open access: yes, 2021
Intermediate report on liaison activities represents the report of the NI4OS-Europe liaison activities in the first 18 months of the project (September 2019 – February 2021)
K.Koumantaros   +6 more
core   +1 more source

NI4OS-Europe Final report on liaison activities

open access: yes, 2023
This document reports on the various liaison activities in the second phase of the NI4OS-Europe project with a focus on the liaison with EOSC Association, projects and communities.
Elli Papadopoulou   +3 more
core   +1 more source

The safety of rush immunotherapy in the management of canine atopic dermatitis—230 cases

open access: yesVeterinary Dermatology, Volume 34, Issue 5, Page 385-392, October 2023., 2023
Background – The duration of the induction phase of allergen‐specific immunotherapy conventionally is a period of several weeks, during which the volume of an allergen solution, administered by injection, is gradually increased until the maintenance dose is reached.
Tamara Weitzer, Ralf Mueller
wiley   +1 more source

NI4OS-Europe Training report

open access: yes, 2022
Training report – provides a summary report of the training activities in the project including national and project-wide training events, development and maintenance of the training platform and catalogue, development of asynchronous training materials,
Sonja Filiposka
core   +1 more source

NI4OS-Europe Update of the service catalogue

open access: yes, 2021
Update of service catalogue based on feedback from WP6 scientific communities, resource providers, and the catalogue development ...
Antun Balaz   +5 more
core   +1 more source

NI4OS-Europe Stakeholder map, inventory, policy matrix update

open access: yes, 2022
Stakeholder map, inventory, policy matrix update: Along with identifying changes in the landscape (new stakeholder clusters within NOSCIs; new inventories; new policies), the deliverable provides the details as captured in the second half of NI4OS-Europe,
Milica Ševkušić, Biljana Kosanović
core   +1 more source

NI4OS-Europe EOSC service and FAIR uptake strategy

open access: yes, 2023
This document is a detailed report of all actions taken to ensure the promotion of EOSC and FAIR uptake in the user ...
Vasiliki Koukounidou   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy